Natera at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Natera brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3455. Its program centres on large B-cell lymphoma. It hosts a showcase on the ALPHA3 trial, which uses residual disease results to guide first-line consolidation with an allogeneic CAR T.
| Organization | ASH 2026 Attendance |
|---|---|
Natera Austin, TX | |
Cell-free DNA testing company offering prenatal, transplant and oncology tests, including the Signatera molecular residual disease assay. | Booth Exhibiting at Booth 3455 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Natera
Tell us what you sell and we’ll find the people at Natera most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction